Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Siebenhaar

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The British Journal of Dermatology|September 30, 2009
Results and relevance of critical temperature threshold testing in patients with acquired cold urticariaA Młynek, M Magerl, F Siebenhaar, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 11, 2010
[Cold-induced urticaria and angioedema. Classification, diagnosis and therapy]K Krause, F Degener, S Altrichter, et al.
Cancer Research|October 4, 2000
p53 is essential for chemotherapy-induced hair lossV A Botchkarev, E A Komarova, F Siebenhaar, et al.
Dermatology (Basel, Switzerland)|February 18, 2006
Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trialP Staubach, K Onnen, A Vonend, et al.
The British Journal of Dermatology|September 30, 2009
Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trialK Hartmann, F Siebenhaar, B Belloni, et al.
The American Journal of Pathology|June 8, 2001
p53 Involvement in the control of murine hair follicle regressionV A Botchkarev, E A Komarova, F Siebenhaar, et al.
Allergy|June 30, 2017
Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observationsS Broesby-Olsen, H Vestergaard, C G Mortz, et al.
Allergy|January 23, 2016
Development and validation of the mastocytosis quality of life questionnaire: MC-QoLF Siebenhaar, E von Tschirnhaus, K Hartmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 30, 2012
Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticariaM Magerl, M Rother, T Bieber, et al.
Experimental Dermatology|March 3, 2005
How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approachesT Biró, M C Ko, B Bromm, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The British Journal of Dermatology|September 30, 2009
Results and relevance of critical temperature threshold testing in patients with acquired cold urticariaA Młynek, M Magerl, F Siebenhaar, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 11, 2010
[Cold-induced urticaria and angioedema. Classification, diagnosis and therapy]K Krause, F Degener, S Altrichter, et al.
Cancer Research|October 4, 2000
p53 is essential for chemotherapy-induced hair lossV A Botchkarev, E A Komarova, F Siebenhaar, et al.
Dermatology (Basel, Switzerland)|February 18, 2006
Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trialP Staubach, K Onnen, A Vonend, et al.
The British Journal of Dermatology|September 30, 2009
Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trialK Hartmann, F Siebenhaar, B Belloni, et al.
The American Journal of Pathology|June 8, 2001
p53 Involvement in the control of murine hair follicle regressionV A Botchkarev, E A Komarova, F Siebenhaar, et al.
Allergy|June 30, 2017
Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observationsS Broesby-Olsen, H Vestergaard, C G Mortz, et al.
Allergy|January 23, 2016
Development and validation of the mastocytosis quality of life questionnaire: MC-QoLF Siebenhaar, E von Tschirnhaus, K Hartmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 30, 2012
Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticariaM Magerl, M Rother, T Bieber, et al.
Experimental Dermatology|March 3, 2005
How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approachesT Biró, M C Ko, B Bromm, et al.
Pageof 4